The objective of the DNA Analysis Shared Resource is to provide Purdue cancer center researchers the following services: I) automated determination of DNA sequences by fluorescence-based dideoxy sequencing methods using Pharmacia ALF Express sequencing equipment and 2) computer analysis of nucleic acid and protein sequences using mainly the Genetic Computer Group (GCG) suite of software operating on a cluster of Digital Equipment Corporation Mfa workstations. Both of these services have proved to be invaluable resources for cancer research and are used extensively by members of the Cell Growth and Differentiation Program Area. Cancer researchers in the Experimental Therapeutics and Diagnostics Program Area and the Structural Biology Program Area also frequently utilize these resources. DNA Sequencing Facility provides state of the art enhanced DNA sequencing capabilities using flourescent labeled primers or internal fluorescent labeling and standard oligonucleotide primers. The DNA templates and unlabeled primers are provided by the individual investigators. The sequencing reactions, gel electrophoretic analysis, and final editing of ambigious sequence calls are performed by DNA Sequencing Lab personnel. The Computational Biochemistry Laboratory provides specialized computing hardware and software for the Purdue cancer research community. The principal activities in the computational facility are analysis of nucleic acid and protein sequences by data base searching, sequence comparison and alignment, pattern recognition, and secondary structure prediction. The shared resource provides enhanced access to all major sequence databases and the Brookhaven crystal structure database via network connections. In addition to providing network access to powerful computer workstations and software, the facility provides training and advice on most aspects of molecular sequence analysis and also provides customized programming when novel sequence analysis questions are posed by cancer researchers. Access to this expertise is a highly valued feature of the Shared Resource.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA023168-22
Application #
6344710
Study Section
Project Start
2000-08-17
Project End
2001-06-30
Budget Start
Budget End
Support Year
22
Fiscal Year
2000
Total Cost
Indirect Cost
Name
Purdue University
Department
Type
DUNS #
072051394
City
West Lafayette
State
IN
Country
United States
Zip Code
47907
Lee, Hyeon Jeong; Li, Jie; Vickman, Renee E et al. (2018) Cholesterol Esterification Inhibition Suppresses Prostate Cancer Metastasis by Impairing the Wnt/?-catenin Pathway. Mol Cancer Res 16:974-985
Bhandari, Pushpak; Novikova, Gloriia; Goergen, Craig J et al. (2018) Ultrasound beam steering of oxygen nanobubbles for enhanced bladder cancer therapy. Sci Rep 8:3112
Dhawan, Deepika; Hahn, Noah M; Ramos-Vara, José A et al. (2018) Naturally-occurring canine invasive urothelial carcinoma harbors luminal and basal transcriptional subtypes found in human muscle invasive bladder cancer. PLoS Genet 14:e1007571
Shinde, Aparna; Libring, Sarah; Alpsoy, Aktan et al. (2018) Autocrine Fibronectin Inhibits Breast Cancer Metastasis. Mol Cancer Res 16:1579-1589
Ghosh, Arun K; Ghosh, Koena; Brindisi, Margherita et al. (2018) Design, synthesis, X-ray studies, and biological evaluation of novel BACE1 inhibitors with bicyclic isoxazoline carboxamides as the P3 ligand. Bioorg Med Chem Lett 28:2605-2610
Thompson, Taylor J; Han, Bumsoo (2018) Analysis of adhesion kinetics of cancer cells on inflamed endothelium using a microfluidic platform. Biomicrofluidics 12:042215
Alpsoy, Aktan; Dykhuizen, Emily C (2018) Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI/SNF chromatin remodeling subcomplexes. J Biol Chem 293:3892-3903
Kumari, Rashmi; Silic, Martin R; Jones-Hall, Yava L et al. (2018) Identification of RECK as an evolutionarily conserved tumor suppressor gene for zebrafish malignant peripheral nerve sheath tumors. Oncotarget 9:23494-23504
Larocque, Elizabeth A; Naganna, N; Opoku-Temeng, Clement et al. (2018) Alkynylnicotinamide-Based Compounds as ABL1 Inhibitors with Potent Activities against Drug-Resistant CML Harboring ABL1(T315I) Mutant Kinase. ChemMedChem 13:1172-1180
Poh, Scott; Chelvam, Venkatesh; Ayala-López, Wilfredo et al. (2018) Selective liposome targeting of folate receptor positive immune cells in inflammatory diseases. Nanomedicine 14:1033-1043

Showing the most recent 10 out of 436 publications